117 related articles for article (PubMed ID: 19127078)
1. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
[TBL] [Abstract][Full Text] [Related]
2. Occult Hepatitis B Virus Infection and Liver Fibrosis in Chinese Patients.
Tang X; Yang L; Zhang P; Wang C; Luo S; Liu B; Fu Y; Candotti D; Allain JP; Zhang L; Li C; Li T
J Infect Dis; 2023 Nov; 228(10):1375-1384. PubMed ID: 37170968
[TBL] [Abstract][Full Text] [Related]
3. Increased liver stiffness promotes hepatitis B progression by impairing innate immunity in CCl4-induced fibrotic HBV
Bybee G; Moeun Y; Wang W; Kharbanda KK; Poluektova LY; Kidambi S; Osna NA; Ganesan M
Front Immunol; 2023; 14():1166171. PubMed ID: 37600826
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus core-related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report.
Yokoyama K; Yamauchi E; Uchida Y; Kitaguchi T; Fukuda H; Yamauchi R; Tsuchiya N; Umeda K; Takata K; Tanaka T; Inomata S; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Clin Case Rep; 2020 Dec; 8(12):3032-3037. PubMed ID: 33363874
[TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication.
Saravanan S; Shankar EM; Vignesh R; Ganesh PS; Sankar S; Velu V; Smith DM; Balakrishnan P; Viswanathan D; Govindasamy R; Venkateswaran AR
J Viral Hepat; 2024 Apr; ():. PubMed ID: 38578122
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of
Ogawa M; Moriyama M; Nakamura H; Shibata T; Kuroda K; Sugitani M
J Clin Biochem Nutr; 2024 Mar; 74(2):169-178. PubMed ID: 38510682
[TBL] [Abstract][Full Text] [Related]
7. The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma.
Moriyama M; Kanda T; Midorikawa Y; Matsumura H; Masuzaki R; Nakamura H; Ogawa M; Matsuoka S; Shibata T; Yamazaki M; Kuroda K; Nakayama H; Higaki T; Kanemaru K; Miki T; Sugitani M; Takayama T
Sci Rep; 2022 Nov; 12(1):20508. PubMed ID: 36443564
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores.
Iacob DG; Luminos M; Benea OE; Tudor AM; Olariu CM; Iacob SA; Ruta S
Front Med (Lausanne); 2022; 9():888050. PubMed ID: 35966860
[TBL] [Abstract][Full Text] [Related]
9. Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection.
Liu S; Zhao K; Su X; Gao X; Yao Y; Kong R; Wang Y; Wu C; Lu M; Chen X; Pei R
Virol Sin; 2022 Jun; 37(3):408-417. PubMed ID: 35523417
[TBL] [Abstract][Full Text] [Related]
10. In silico analysis of mutations associated with occult hepatitis B virus (HBV) infection in South Africa.
Olagbenro M; Anderson M; Gaseitsiwe S; Powell EA; Gededzha MP; Selabe SG; Blackard JT
Arch Virol; 2021 Nov; 166(11):3075-3084. PubMed ID: 34468889
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.
Nguyen MH; Wong G; Gane E; Kao JH; Dusheiko G
Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102898
[TBL] [Abstract][Full Text] [Related]
12. Occult HBV infection status and its impact on surgical outcomes in patients with curative resection for HCV-associated hepatocellular carcinoma.
Yamaji K; Kai K; Komukai S; Koga H; Ide T; Kawaguchi A; Noshiro H; Aishima S
Hepatobiliary Surg Nutr; 2018 Dec; 7(6):443-453. PubMed ID: 30652089
[TBL] [Abstract][Full Text] [Related]
13. In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.
Anderson M; Choga WT; Moyo S; Bell TG; Mbangiwa T; Phinius BB; Bhebhe L; Sebunya TK; Makhema J; Marlink R; Kramvis A; Essex M; Musonda RM; Blackard JT; Gaseitsiwe S
Genes (Basel); 2018 Aug; 9(9):. PubMed ID: 30134551
[TBL] [Abstract][Full Text] [Related]
14. Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection.
Nirei K; Kanda T; Nakamura H; Matsuoka S; Takayama T; Sugitani M; Moriyama M
Int J Med Sci; 2018; 15(5):466-474. PubMed ID: 29559835
[No Abstract] [Full Text] [Related]
15. Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma.
Koga H; Kai K; Aishima S; Kawaguchi A; Yamaji K; Ide T; Ueda J; Noshiro H
World J Hepatol; 2017 Dec; 9(35):1286-1295. PubMed ID: 29290910
[TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH
World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431
[TBL] [Abstract][Full Text] [Related]
17. Update on occult hepatitis B virus infection.
Makvandi M
World J Gastroenterol; 2016 Oct; 22(39):8720-8734. PubMed ID: 27818588
[TBL] [Abstract][Full Text] [Related]
18. Role of occult hepatitis B virus infection in chronic hepatitis C.
Coppola N; Onorato L; Pisaturo M; Macera M; Sagnelli C; Martini S; Sagnelli E
World J Gastroenterol; 2015 Nov; 21(42):11931-40. PubMed ID: 26576082
[TBL] [Abstract][Full Text] [Related]
19. Establishing the link between hepatitis B virus infection and colorectal adenoma.
Patel BB; Lipka S; Shen H; Davis-Yadley AH; Viswanathan P
J Gastrointest Oncol; 2015 Oct; 6(5):492-7. PubMed ID: 26487942
[TBL] [Abstract][Full Text] [Related]
20. MiR-122 in hepatitis B virus and hepatitis C virus dual infection.
Song K; Han C; Dash S; Balart LA; Wu T
World J Hepatol; 2015 Mar; 7(3):498-506. PubMed ID: 25848473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
